Kimberly Eadie

589 total citations
30 papers, 422 citations indexed

About

Kimberly Eadie is a scholar working on Small Animals, Microbiology and Epidemiology. According to data from OpenAlex, Kimberly Eadie has authored 30 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Small Animals, 16 papers in Microbiology and 11 papers in Epidemiology. Recurrent topics in Kimberly Eadie's work include Infectious Diseases and Mycology (17 papers), Actinomycetales infections and treatment (16 papers) and Pneumonia and Respiratory Infections (5 papers). Kimberly Eadie is often cited by papers focused on Infectious Diseases and Mycology (17 papers), Actinomycetales infections and treatment (16 papers) and Pneumonia and Respiratory Infections (5 papers). Kimberly Eadie collaborates with scholars based in Netherlands, Sudan and Switzerland. Kimberly Eadie's co-authors include Wendy W. J. van de Sande, Ahmed Hassan Fahal, Alex van Belkum, Wilson Lim, Henri A. Verbrugh, Annelies Verbon, Guus Simons, Martin Reijans, Corné H. W. Klaassen and Alphons M. Horrevorts and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Bacteriology.

In The Last Decade

Kimberly Eadie

29 papers receiving 414 citations

Peers

Countries citing papers authored by Kimberly Eadie

Since Specialization

Citations

This map shows the geographic impact of Kimberly Eadie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Eadie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Eadie more than expected).

Fields of papers citing papers by Kimberly Eadie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Eadie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Eadie. The network helps show where Kimberly Eadie may publish in the future.

Co-authorship network of co-authors of Kimberly Eadie

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Eadie. A scholar is included among the top collaborators of Kimberly Eadie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Eadie. Kimberly Eadie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella 2025 ·Nature Communications ·Imad Abugessaisa, (unknown), Ri‐Ichiroh Manabe, C. K. Murphy, Tsugumi Kawashima, Akira Hasegawa, (unknown), Michihira Tagami, Yasushi Okazaki, Kimberly Eadie, Wilson Lim, Seán Doyle, Annelies Verbon, Ahmed Hassan Fahal, Takeya Kasukawa, Wendy W. J. van de Sande	0
2	The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma 2025 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Emmanuel Edwar Siddig, Kimberly Eadie, (unknown), (unknown), Doudou Sow, Ahmed Hassan Fahal, Annelies Verbon, Wendy W. J. van de Sande	1
3	Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease 2024 ·European Journal of Medicinal Chemistry ·(unknown), Pierre‐Olivier Delaye, (unknown), Kimberly Eadie, Magdi Awadalla Mohamed, Pierre Besson, (unknown), Guillaume Désoubeaux, Sébastien Roger, (unknown), Ahmed Hassan Fahal, Cécile Enguehard‐Gueiffier	3
4	The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis 2024 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·(unknown), Kimberly Eadie, Ahmed Hassan Fahal, Annelies Verbon, Wendy W. J. van de Sande	3
5	Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against Madurella mycetomatis 2024 ·International Journal of Molecular Sciences ·(unknown), Kimberly Eadie, (unknown), Ahmed Hassan Fahal, Benoı̂t Laleu, Annelies Verbon, Wendy W. J. van de Sande	5
6	The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo 2023 ·Medical Mycology ·(unknown), Kimberly Eadie, (unknown), (unknown), Ahmed Hassan Fahal, Annelies Verbon, Wendy W. J. van de Sande	5
7	Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma 2022 ·PLoS neglected tropical diseases ·Wilson Lim, (unknown), Kimberly Eadie, (unknown), (unknown), Ahmed Hassan Fahal, Alexandro Bonifáz, Matthew H. Todd, Benjamin Perry, Kirandeep Samby, Jeremy N. Burrows, Annelies Verbon, Wendy W. J. van de Sande	29
8	The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma 2021 ·PLoS neglected tropical diseases ·(unknown), Kimberly Eadie, Wilson Lim, Ahmed Hassan Fahal, Johan W. Mouton, (unknown), Wendy W. J. van de Sande	7
9	The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach 2020 ·PLoS neglected tropical diseases ·Wilson Lim, Emmanuel Edwar Siddig, Kimberly Eadie, (unknown), Sarah Ahmed, Ahmed Hassan Fahal, Annelies Verbon, Sandra Smit, Wendy W. J. van de Sande	16
10	A Short-Tandem-Repeat Assay ( Mmy STR) for Studying Genetic Variation in Madurella mycetomatis 2020 ·Journal of Clinical Microbiology ·(unknown), Kimberly Eadie, (unknown), Sarah Ahmed, Marie Desnos‐Ollivier, Ahmed Hassan Fahal, Sybren de Hoog, Annelies Verbon, Wendy W. J. van de Sande, Corné H. W. Klaassen	8
11	VNTR confirms the heterogeneity ofMadurella mycetomatisand is a promising typing tool for this mycetoma causing agent 2018 ·Medical Mycology ·Wilson Lim, Kimberly Eadie, Deborah Horst-Kreft, Sarah Ahmed, Ahmed Hassan Fahal, Wendy W. J. van de Sande	8
12	Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma 2018 ·PLoS neglected tropical diseases ·Wilson Lim, (unknown), (unknown), (unknown), Kimberly Eadie, Benoı̂t Laleu, Benjamin I. Perry, Matthew H. Todd, Jean‐Robert Ioset, Wendy W. J. van de Sande	28
13	Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy 2017 ·PLoS ONE ·(unknown), Alieke G. Vonk, Marian T. ten Kate, Kimberly Eadie, Henri A. Verbrugh, Irma A. J. M. Bakker‐Woudenberg, Wendy W. J. van de Sande	3
14	A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study 2015 ·PLoS neglected tropical diseases ·(unknown), (unknown), Kimberly Eadie, Ahmed Hassan Fahal, Henri A. Verbrugh, Wendy W. J. van de Sande	20
15	Double-Stranded RNA Mycovirus Infection of Aspergillus fumigatus Is Not Dependent on the Genetic Make-Up of the Host 2013 ·PLoS ONE ·(unknown), Alieke G. Vonk, Kimberly Eadie, Jerome R. Lo-Ten-Foe, Henri A. Verbrugh, Anne D. van Diepeningen, Wendy W. J. van de Sande	21
16	Device-independent, real-time identification of bacterial pathogens with a metal oxide-based olfactory sensor 2009 ·European Journal of Clinical Microbiology & Infectious Diseases ·Marjan J. Bruins, (unknown), P. L. C. Petit, Kimberly Eadie, (unknown), Rolf Bos, Gabriëlle H. van Ramshorst, Alex van Belkum	41
17	High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis 2006 ·Clinical Microbiology and Infection ·John P. Hays, (unknown), G. Simons, Justine Peeters, Kimberly Eadie, Cees M. Verduin, Henri A. Verbrugh, Alex van Belkum	4
18	Direct detection of human Staphylococcus aureus carriage in the nose using the Lightcycler Staphylococcus kit 2005 ·Journal of Microbiological Methods ·(unknown), Damian C. Melles∗, Kimberly Eadie, Martine De Vos, Heiman Wertheim, (unknown), Alex van Belkum, Willem B. van Leeuwen	6
19	Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children 2004 ·European Journal of Clinical Microbiology & Infectious Diseases ·John P. Hays, Kimberly Eadie, Reinier H. Veenhoven, (unknown), Henri A. Verbrugh, Alex van Belkum	2
20	A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis 2003 ·Journal of Microbiological Methods ·Nicole van den Braak, Guus Simons, (unknown), Martin Reijans, Kimberly Eadie, (unknown), Dick van Soolingen, Paul H. M. Savelkoul, Henri A. Verbrugh, Alex van Belkum	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact